Observational studyAdvances in therapy2019

Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRC.

Holger Hebart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.